XBiotech XBIT Income Statement (2014-2026)

NASDAQ XBIT
$2.28 -0.03 (-1.30%)
As of: Aug 20, 2026 · 3:58 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity) (Quarter)
30.02M30.40M30.44M30.44M30.44M30.44M30.44M30.44M30.43M30.44M30.44M30.45M30.46M30.48M30.49M30.49M30.49M30.49M30.49M
Revenue & cost
Revenue (Quarter)
4.53M4.52M0.50M1.53M1.68M0.30M
Gross Profit (Quarter)
3.17M3.41M3.45M0.29M1.32M1.47M0.28M
Operating items
Research & Development (Quarter)
9.25M5.60M8.78M6.82M10.39M7.01M7.32M6.23M11.27M7.55M7.80M9.82M12.98M7.13M7.82M11.62M5.34M5.08M25.36M5.30M
Selling, General & Administrative (Quarter)
4.52M1.54M1.87M1.31M3.02M0.84M1.13M0.92M1.99M0.97M0.78M1.03M1.98M0.78M0.93M1.93M1.00M0.97M4.40M0.85M
Operating Expenses (Quarter)
13.77M7.14M10.65M8.13M13.42M7.85M8.45M7.14M13.26M8.52M8.59M10.85M14.97M7.90M8.75M13.55M6.34M6.05M29.75M6.15M
Operating Income (Quarter)
-10.61M-3.73M-7.19M-7.84M-12.09M-6.39M-8.16M-7.14M-13.26M-8.52M-8.59M-10.85M-14.97M-7.90M-8.75M-13.55M-6.34M-6.05M-29.75M-6.15M
EBIT (Quarter)
-10.61M-3.73M-7.19M-7.84M-12.09M-6.39M-8.16M-7.14M-13.26M-8.52M-8.59M-10.85M-14.97M-7.90M-8.75M-13.55M-6.34M-6.05M-29.75M-6.15M
Non-operating items
Interest & Investment Income (Quarter)
0.12M0.12M0.11M0.10M0.24M1.01M2.47M2.78M2.51M2.53M2.60M2.66M2.69M2.37M2.10M1.50M1.53M1.43M1.22M0.89M
Other Non Operating Income (Quarter)
-0.00M-1.33M-0.58M-0.12M3.07M0.13M0.75M-1.06M1.01M0.03M0.41M0.28M-0.00M-0.09M1.10M-1.41M
Non Operating Income (Quarter)
0.91M-1.32M-0.47M1.39M-2.16M-3.87M5.54M3.29M4.59M1.46M13.20M0.88M1.94M-0.20M-1.80M-0.09M4.61M0.14M2.94M-0.54M
Net income details
EBT (Quarter)
-9.69M-5.05M-7.67M-6.45M-14.25M-10.26M-2.62M-3.85M-8.67M-7.06M-4.73M-9.98M-13.03M-5.01M-10.55M-10.86M-1.73M-5.91M-26.82M-6.68M
Tax Provisions (Quarter)
-4.57M-1.79M-2.61M-1.06M-2.61M2.40M0.58M0.04M0.07M0.31M-0.04M0.03M-0.03M0.01M-0.04M0.03M0.03M0.10M0.08M0.05M
Profit After Tax (Quarter)
-5.12M-3.26M-6.47M-5.39M-11.64M-12.66M-3.20M-3.82M-8.74M-7.36M-4.63M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Income from Non-Controlling Interests (Quarter)
0.10M
Income from Continuing Operations (Quarter)
-5.12M-3.26M-5.06M-5.39M-11.64M-12.66M-3.20M-3.89M-8.74M-7.36M-4.69M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Consolidated Net Income (Quarter)
-5.12M-3.26M-5.06M-5.39M-11.64M-12.66M-3.20M-3.89M-8.74M-7.36M-4.69M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Income towards Parent Company (Quarter)
-5.12M-3.26M-5.06M-5.39M-11.64M-12.66M-3.20M-3.89M-8.74M-7.36M-4.69M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Net Income towards Common Stockholders (Quarter)
-5.12M-3.26M-5.06M-5.39M-11.64M-12.66M-3.20M-3.89M-8.74M-7.36M-4.69M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Additional items
EPS (Basic) (Quarter)
-0.17-0.11-0.17-0.18-0.38-0.42-0.11-0.13-0.29-0.24-0.15-0.33-0.43-0.16-0.34-0.36-0.06-0.20-0.88-0.22
EPS (Diluted) (Quarter)
-0.17-0.11-0.17-0.18-0.39-0.42-0.11-0.13-0.29-0.24-0.15-0.33-0.43-0.16-0.34-0.36-0.06-0.20-0.88-0.22
Shares Outstanding (Quarter)
29.99M30.34M30.04M30.04M30.44M30.44M30.44M30.44M30.44M30.44M30.44M30.44M30.46M30.47M30.46M30.49M30.49M30.49M30.49M30.49M
Shares Outstanding (Diluted) (Quarter)
30.82M30.82M30.04M30.04M30.04M30.04M30.44M30.44M30.44M30.44M30.44M30.44M30.44M30.44M30.46M30.46M30.46M30.46M30.49M30.49M
EBITDA (Quarter)
-10.61M-3.73M-7.19M-7.84M-12.09M-6.39M-8.16M-7.14M-13.26M-8.52M-8.59M-10.85M-14.97M-7.90M-8.75M-13.55M-6.34M-6.05M-29.75M-6.15M
Interest Expenses (Quarter)
6.47M1.70M70.00M0.40M-0.40M0.40M0.49M
Tax Rate (Quarter)
47.1935.4934.0616.4118.30-23.41-22.02-0.96-0.82-4.370.84-0.250.19-0.180.39-0.27-1.62-1.73-0.28-0.69